ArticleMolecules (Basel, Switzerland)2021

Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.

Sonia Burgaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.